AU659421B2 - Medicaments containing sulphonamides, novel sulphonamides and proces for producing them - Google Patents

Medicaments containing sulphonamides, novel sulphonamides and proces for producing them Download PDF

Info

Publication number
AU659421B2
AU659421B2 AU89057/91A AU8905791A AU659421B2 AU 659421 B2 AU659421 B2 AU 659421B2 AU 89057/91 A AU89057/91 A AU 89057/91A AU 8905791 A AU8905791 A AU 8905791A AU 659421 B2 AU659421 B2 AU 659421B2
Authority
AU
Australia
Prior art keywords
der
tert
butyl
hydroxy
denotes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU89057/91A
Other languages
English (en)
Other versions
AU8905791A (en
Inventor
Hans Alois Dresel
Reinhard Heck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Publication of AU8905791A publication Critical patent/AU8905791A/en
Application granted granted Critical
Publication of AU659421B2 publication Critical patent/AU659421B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/12—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
    • C07C311/13—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings the carbon skeleton containing six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/03—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C311/04—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/17—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C07C311/38—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton
    • C07C311/39—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/40—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/45—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
    • C07C311/46—Y being a hydrogen or a carbon atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Vascular Medicine (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyridine Compounds (AREA)
AU89057/91A 1990-11-22 1991-11-19 Medicaments containing sulphonamides, novel sulphonamides and proces for producing them Ceased AU659421B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4037174A DE4037174A1 (de) 1990-11-22 1990-11-22 Neue sulfonamide, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten
DE4037174 1990-11-22
PCT/EP1991/002186 WO1992009571A1 (de) 1990-11-22 1991-11-19 Sulfonamide enthaltende arzneimittel, neue sulfonamide und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
AU8905791A AU8905791A (en) 1992-06-25
AU659421B2 true AU659421B2 (en) 1995-05-18

Family

ID=6418735

Family Applications (1)

Application Number Title Priority Date Filing Date
AU89057/91A Ceased AU659421B2 (en) 1990-11-22 1991-11-19 Medicaments containing sulphonamides, novel sulphonamides and proces for producing them

Country Status (16)

Country Link
EP (1) EP0558569B1 (enExample)
JP (1) JPH06502632A (enExample)
AT (1) ATE117674T1 (enExample)
AU (1) AU659421B2 (enExample)
CA (1) CA2096847A1 (enExample)
DE (2) DE4037174A1 (enExample)
FI (1) FI932323A0 (enExample)
HU (1) HUT68277A (enExample)
IE (1) IE914044A1 (enExample)
IL (1) IL100120A0 (enExample)
MX (1) MX9102127A (enExample)
NZ (1) NZ240630A (enExample)
PT (1) PT99572A (enExample)
TW (1) TW264466B (enExample)
WO (1) WO1992009571A1 (enExample)
ZA (1) ZA919206B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5491170A (en) * 1994-12-19 1996-02-13 Warner-Lambert Company β-carboxy sulfonamide ACAT inhibitors
KR20150135332A (ko) 2013-03-14 2015-12-02 더 보드 오브 트러스티스 오브 더 리랜드 스탠포드 쥬니어 유니버시티 미토콘드리아 알데히드 탈수소효소-2 조절인자들 및 이들의 사용 방법

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU508419B2 (en) * 1978-03-04 1980-03-20 Boehringer Mannheim Gmbh Phenoxyalkylcarboxylic acid derivatives
AU597707B2 (en) * 1986-08-06 1990-06-07 Tanabe Seiyaku Co., Ltd. Sulphonamide containing phenoxyacetic acid derivatives and their preparation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3737316A (en) * 1971-08-31 1973-06-05 Eastman Kodak Co Two-equivalent sulfonamido couplers
US3801321A (en) * 1972-07-18 1974-04-02 Eastman Kodak Co Photothermographic element,composition and process
US4013621A (en) * 1975-04-29 1977-03-22 Ciba-Geigy Corporation Substituted sulfonamide derivatives of hindered phenols and stabilized compositions
DE68909958D1 (de) * 1988-01-19 1993-11-25 Tanabe Seiyaku Co Phenoxyessigsäure-Derivate, ihre Herstellung, pharmazeutische Zusammensetzungen, die sie enthalten, und deren Verwendung.

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU508419B2 (en) * 1978-03-04 1980-03-20 Boehringer Mannheim Gmbh Phenoxyalkylcarboxylic acid derivatives
AU597707B2 (en) * 1986-08-06 1990-06-07 Tanabe Seiyaku Co., Ltd. Sulphonamide containing phenoxyacetic acid derivatives and their preparation

Also Published As

Publication number Publication date
DE4037174A1 (de) 1992-05-27
NZ240630A (en) 1994-12-22
FI932323L (fi) 1993-05-21
FI932323A7 (fi) 1993-05-21
EP0558569A1 (de) 1993-09-08
HUT68277A (en) 1995-06-28
PT99572A (pt) 1992-10-30
ATE117674T1 (de) 1995-02-15
TW264466B (enExample) 1995-12-01
HU9301498D0 (en) 1993-09-28
IE914044A1 (en) 1992-06-03
WO1992009571A1 (de) 1992-06-11
JPH06502632A (ja) 1994-03-24
EP0558569B1 (de) 1995-01-25
CA2096847A1 (en) 1992-05-23
IL100120A0 (en) 1992-08-18
FI932323A0 (fi) 1993-05-21
AU8905791A (en) 1992-06-25
ZA919206B (en) 1992-08-26
MX9102127A (es) 1992-07-08
DE59104443D1 (de) 1995-03-09

Similar Documents

Publication Publication Date Title
CN1630629B (zh) 酯化合物及其医药用途
JP2003504403A (ja) リン酸輸送阻害物質
US6458845B1 (en) Macrophage scavenger receptor antagonists
EP1773315B1 (en) Arylacetic acids and related compounds for treatment of alzheimer's disease
BRPI0620520A2 (pt) agentes ligantes de receptores nucleares
AU659421B2 (en) Medicaments containing sulphonamides, novel sulphonamides and proces for producing them
WO2000003704A1 (en) Macrophage scavenger receptor antagonists
US6117909A (en) Methods of using sulfamic acid derivatives for lowering serum or plasma level of Lp(a)
CA2298824A1 (en) Macrophage scavenger receptor antagonists for use in the treatment of cardiovascular diseases
US5391551A (en) Method of lowering blood lipid levels
WO2017216579A1 (en) Autophagy inducer compounds
JPS6025969A (ja) アレルギ−治療用組成物
EP0588799B1 (de) Neue sulfonamide, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten
CA2143000C (en) Non-metabolizable clomiphene analogs for treatment of tamoxifen-resistant tumors
WO2000006147A1 (en) Macrophage scavenger receptor antagonists
FR2763847A1 (fr) Utilisation de tetrahydropyridines 4-substituees pour fabriquer des medicaments agissant sur le tgf-beta-1
JP2002523461A (ja) 神経変性疾患の治療方法
EP1481670A1 (en) Medicinal composition for diagnosis, prevention, or therapy of multiple risk factor syndrome
WO2001098264A1 (en) Macrophage scavenger receptor antagonists
JPH05949A (ja) 腎機能改善および腎保護剤
MXPA97009275A (en) Use of derivatives of sulfamic acid, acil sulfonamides or sulfonil carbamates for the manufacture of a medicinal product to reduce delipoprotei levels
EP0766962A2 (en) Treatment of atherosclerosis